Hermetica Superfood Encyclopedia
The Short Answer
Elfvingia applanata contains lanostane triterpenoids (applanaic acids A–C) and crude hot water-soluble polysaccharides that drive host-mediated immunostimulation by activating macrophages, B lymphocytes, and the complement cascade while inducing apoptosis via G1 cell cycle arrest and NF-κB inhibition. In preclinical models, its hot water fraction (Fr. HW) at 50 µg/mL induced 12.5 µM nitric oxide in RAW 264.7 macrophages and increased B lymphocyte alkaline phosphatase activity up to 8.3-fold at 500 µg/mL, extending survival in Sarcoma 180 tumor-bearing mice.
CategoryMushroom
GroupMushroom/Fungi
Evidence LevelPreliminary
Primary KeywordElfvingia applanata benefits
Elfvingia applanata — botanical close-up
Health Benefits
**Immunostimulation via Macrophage Activation**
The hot water polysaccharide fraction (Fr. HW) stimulates RAW 264.7 macrophages to produce 12.5 µM nitric oxide at 50 µg/mL, approaching levels induced by lipopolysaccharide (15.2 µM), suggesting potent innate immune priming through pattern recognition receptor engagement.
**B Lymphocyte Proliferation and Antibody Support**: Fr
HW increases B lymphocyte alkaline phosphatase (APase) activity by 3.72-fold at 50 µg/mL and up to 8.3-fold at 500 µg/mL, indicating dose-dependent adaptive immune enhancement that may support humoral immunity.
**Antitumor Activity in Animal Models**: Intraperitoneal administration of Fr
HW extended mean survival in ICR mice bearing Sarcoma 180 tumors, attributed to immunostimulatory rather than direct cytotoxic mechanisms, consistent with host-mediated antitumor defense.
**Apoptosis Induction by Lanostane Triterpenoids**
Applanaic acids and related lanostanoids arrest cancer cell cycles at G1 phase, upregulate pro-apoptotic proteins p53 and Bax, and suppress Erk1/2 phosphorylation, halting proliferation of Ehrlich ascites and Kato III gastric cancer cells in vitro.
**NF-κB and AP-1 Pathway Inhibition**
Lanostanoid compounds suppress transcription factor activity of NF-κB and AP-1, reducing pro-inflammatory and pro-survival gene expression in tumor cells, potentially limiting cancer cell resistance to apoptotic signals.
**Complement System Activation and Anti-complementary Activity**: Endo-biopolymers from submerged culture demonstrate up to 49.1% anti-complementary activity, indicating modulation of the complement cascade that correlates with observed antitumor effects and immune surveillance enhancement.
**Hepatoprotection and Hepatitis B Inhibition**
Traditional use and preliminary phytochemical data suggest that triterpenoid constituents contribute to hepatoprotective effects and inhibition of hepatitis B virus replication, consistent with the broader hepatoprotective pharmacology observed across lanostane-class compounds in related Ganoderma species.
Origin & History
Natural habitat
Elfvingia applanata is a bracket fungus (shelf mushroom) distributed widely across temperate and boreal forests of Europe, North America, and Asia, typically growing as a perennial polypore on the deadwood or wounded bark of deciduous trees such as beech, oak, and willow. It produces large, woody, fan-shaped fruiting bodies with a characteristic brown spore-dusted upper surface and a white pore surface that darkens when scratched, giving rise to its common name 'artist's conk.' The fungus fruits year-round, with mycelium cultivated in submerged liquid culture for biopolymer production, while wild fruiting bodies are harvested for hot water extract preparation.
“Elfvingia applanata has been utilized in folk medicine across East Asia and Eastern Europe, where the large perennial fruiting bodies were prepared as decoctions intended to treat cancers of the esophagus and stomach, as well as to suppress hepatitis B virus activity, reflecting the broader cultural tradition of bracket fungi as potent medicinal agents. In traditional Chinese and Japanese medicine, it occupies a peripheral but recognized role relative to the more celebrated Ganoderma lucidum (reishi), sharing the lanostanoid chemical heritage that underpins the hepatoprotective and immunomodulatory reputation of the entire Ganodermataceae family. The species' common name 'artist's conk' derives from the practice of etching images onto the white pore surface, which permanently darkens on contact—this non-medicinal cultural use spread across indigenous communities in North America and Europe who recognized the fungus without necessarily employing it therapeutically. No classical pharmacopoeial monographs or datable historical texts specifically codifying its medicinal dose or preparation have been identified, suggesting its use was largely regional and informal rather than institutionalized within major traditional medicine systems.”Traditional Medicine
Scientific Research
The evidence base for Elfvingia applanata consists entirely of preclinical in vitro and in vivo studies, with no published human clinical trials identified to date, placing its evidence at a preliminary level. Key in vitro data include dose-response experiments in RAW 264.7 macrophage and B lymphocyte cultures demonstrating nitric oxide induction and APase activity at concentrations of 5–500 µg/mL Fr. HW, and cytotoxicity screening of applanaic acid analogs against Ehrlich and Kato III cancer cell lines. In vivo data derive from Sarcoma 180 tumor models in ICR mice (n=8 per group) using intraperitoneal injection of Fr. HW, reporting extended survival attributed to immunostimulation, though exact survival values and confidence intervals were not fully quantified in available reports. The research gap is substantial: precise bioactive compound concentrations in commercial extracts, oral bioavailability, effective human doses, and safety data in humans remain entirely unestablished.
Preparation & Dosage
Traditional preparation
**Hot Water Extract (Fr. HW)**
Prepared by decocting dried fruiting bodies in water at elevated temperatures, yielding crude polysaccharide-rich fractions; in vitro effective concentrations ranged from 5–500 µg/mL, with immunostimulatory effects observed as low as 50 µg/mL—no validated human oral dose equivalent established.
**Submerged Culture Biopolymers**
Endo- and exo-biopolymers produced by fermenting mycelium in liquid culture; endo-biopolymers showed up to 49.1% anti-complementary activity in vitro, but no commercial standardization or dosing protocol exists.
**Traditional Decoction**
Fruiting bodies boiled in water for extended periods (1–4 hours) and consumed as a tea or concentrated broth, consistent with traditional East Asian medicinal mushroom preparation practices; no standardized volume or frequency documented.
**Crude Powdered Fruiting Body**
Ground dried bracket fungus incorporated into capsules or powders; no standardization percentage for polysaccharide or triterpenoid content established for this species specifically.
**Standardization Note**
Unlike Ganoderma lucidum products standardized to polysaccharide (≥30%) or triterpenoid (≥4%) content, no pharmacopoeial or industry standard exists for E. applanata; consumers should treat any commercial product as experimental until dosing studies are published.
Nutritional Profile
As a woody polypore, Elfvingia applanata fruiting bodies contain substantial structural polysaccharides including beta-1,3/1,6-glucans and heteropolysaccharides (crude hot water-soluble fraction), which constitute the primary bioactive and nutritional polymer content, though exact percentages in the raw material are unquantified for this species. Lanostane triterpenoids—including applanaic acids A, B, and C, characterized by highly oxygenated tetracyclic skeletons with Δ17(20)-double bonds in some variants—are present at concentrations that remain unquantified in standardized extract preparations. The fruiting bodies likely contain trace minerals (potassium, magnesium, zinc, selenium) and ergosterol (a provitamin D2 precursor) consistent with basidiomycete fungi generally, though species-specific nutritional analyses for E. applanata have not been published. Bioavailability of oral polysaccharides is inherently limited by gastrointestinal degradation; the extent to which lanostanoids survive first-pass hepatic metabolism following oral ingestion has not been studied in this species.
How It Works
Mechanism of Action
The polysaccharide fraction of Elfvingia applanata (Fr. HW) acts as a biological response modifier by binding pattern recognition receptors on macrophages and B lymphocytes, stimulating splenocyte proliferation 2.53-fold and driving nitric oxide synthase induction for cytotoxic immune effector activity. Lanostane triterpenoids, including applanaic acids A–C, penetrate target cells and upregulate tumor suppressor p53 and pro-apoptotic Bax while downregulating anti-apoptotic signaling, arresting cell cycle progression at the G1/S checkpoint. Simultaneously, these triterpenoids inhibit phosphorylation of Erk1/2 MAP kinase and block the transcriptional activity of NF-κB and AP-1, suppressing survival gene expression in malignant cells without equivalent toxicity to normal cells. Complement pathway modulation by endo-biopolymers further amplifies immune-mediated tumor clearance, creating a dual mechanism of direct proapoptotic signaling and indirect host immune activation.
Clinical Evidence
No human clinical trials have been conducted on Elfvingia applanata or its isolated fractions as of current available literature, making definitive clinical conclusions impossible. Preclinical evidence from mouse tumor models using intraperitoneal Fr. HW administration demonstrated extended survival in Sarcoma 180-bearing ICR mice, though exact effect sizes, confidence intervals, and dose–response relationships were not fully reported. In vitro immunostimulatory outcomes are quantified and internally consistent—8.3-fold APase induction and 12.5 µM NO production represent meaningful biological signals—but their translation to oral supplementation in humans is entirely speculative. The overall confidence in clinical benefit is very low; all reported outcomes must be regarded as hypothesis-generating preclinical findings requiring validation in controlled human trials.
Safety & Interactions
No human safety data, adverse event reports, or toxicological studies have been published for Elfvingia applanata, making any safety characterization necessarily speculative and based on preclinical observations. In vitro and murine studies at doses up to 500 µg/mL (in vitro) showed no direct cytotoxicity to normal cells and positive immunostimulation without reported adverse events, suggesting a favorable preclinical safety signal but insufficient basis for human safety conclusions. One lanostanoid analog demonstrated weak acetylcholinesterase inhibition at 33.5% inhibition at 50 µM in vitro, raising a theoretical concern for additive effects with cholinesterase inhibitor drugs (e.g., donepezil, rivastigmine) or organophosphate compounds, though clinical relevance at realistic exposure levels is entirely unknown. Pregnant or lactating individuals, immunocompromised patients on immunosuppressive therapy (e.g., calcineurin inhibitors, corticosteroids), and individuals with autoimmune conditions should avoid use given the potent immunostimulatory activity and complete absence of safety data in these populations.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Ganoderma applanatumArtist's ConkBear BreadFomes applanatusPolyporus applanatusElfvingia applanata (Pers.) P. Karst.
Frequently Asked Questions
What is Elfvingia applanata used for medicinally?
Elfvingia applanata has been traditionally used to treat esophageal and stomach cancers and to inhibit hepatitis B virus. Modern preclinical research focuses on its hot water polysaccharide extract (Fr. HW) for immunostimulation—including macrophage activation and B lymphocyte proliferation—and on its lanostane triterpenoids (applanaic acids A–C) for apoptosis induction in cancer cells via G1 arrest, NF-κB suppression, and Bax upregulation. No human clinical trials have confirmed these effects.
Is Elfvingia applanata the same as Ganoderma applanatum?
Elfvingia applanata and Ganoderma applanatum refer to the same bracket fungus species; the name Ganoderma applanatum is the more widely used synonym in modern mycological literature, while Elfvingia applanata reflects an older taxonomic classification. Both names appear in the scientific literature, and the species shares the lanostane triterpenoid chemistry characteristic of the broader Ganodermataceae family, though it is pharmacologically distinct from the more extensively studied Ganoderma lucidum (reishi).
What are the active compounds in Elfvingia applanata?
The primary bioactive compounds are hot water-soluble polysaccharides (crude beta-glucan-rich fraction, Fr. HW) and lanostane triterpenoids including applanaic acids A, B, and C—highly oxygenated tetracyclic compounds, some featuring Δ17(20)-double bonds. The polysaccharides drive immunostimulation by activating macrophages and B lymphocytes, while the triterpenoids induce apoptosis in cancer cells by inhibiting Erk1/2 phosphorylation, upregulating p53 and Bax, and blocking NF-κB and AP-1 transcription.
Are there any clinical trials on Elfvingia applanata?
No human clinical trials on Elfvingia applanata or its isolated fractions have been published as of current available literature. All evidence comes from in vitro cell culture studies and in vivo mouse tumor models (Sarcoma 180, ICR mice, n=8 per group), limiting the ability to draw conclusions about efficacy or safety in humans. Researchers identify human trials, standardized dosing studies, and pharmacokinetic investigations as critical unmet needs.
What is the recommended dose of Elfvingia applanata extract?
No validated human dose has been established for Elfvingia applanata because no clinical trials or pharmacokinetic studies in humans have been conducted. Preclinical in vitro studies used Fr. HW concentrations of 5–500 µg/mL, with immunostimulatory effects observed at 50 µg/mL; in vivo mouse studies administered extracts intraperitoneally at unspecified doses. Until human dose-finding studies are completed, no safe or effective supplemental dose can be recommended.
Does Elfvingia applanata interact with immunosuppressant medications?
Elfvingia applanata's potent macrophage-activating polysaccharides may potentially counteract immunosuppressant drugs used after organ transplants or for autoimmune conditions. Individuals taking immunosuppressive medications should consult their healthcare provider before supplementing with Elfvingia applanata to avoid therapeutic interference. The hot water polysaccharide fraction stimulates nitric oxide production and B lymphocyte activity, which could theoretically reduce the efficacy of immunosuppressive therapy.
What is the difference between hot water extract and alcohol extract of Elfvingia applanata?
Hot water extracts (Fr. HW) of Elfvingia applanata are enriched in polysaccharides that demonstrate strong macrophage activation and B lymphocyte proliferation, making them the primary form studied for immune support. Alcohol extracts typically concentrate triterpenes and other lipophilic compounds that may have different bioactive properties than the polysaccharide-rich hot water fraction. For immune-stimulating benefits supported by research, hot water extracts show superior efficacy compared to alcohol-based preparations.
Who should avoid taking Elfvingia applanata supplements?
Individuals with overactive immune conditions such as lupus, rheumatoid arthritis, or those taking immunosuppressants should avoid Elfvingia applanata due to its strong immune-stimulating properties via macrophage and B lymphocyte activation. People with known mushroom allergies should exercise caution, as cross-reactivity is possible. Pregnant and nursing women should consult healthcare providers before use, as safety data in these populations remains limited.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w elfvingia-applanata-ganoderma-applanatum curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
